Left Menu
Development News Edition

Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes


 A new systematic literature review and meta-analysis[1] confirms and extends previous results that omega-3 (ω-3) fatty-acid enriched parenteral nutrition (PN) improves clinical outcomes compared with standard PN in adult patients. Including a total of 49 randomized controlled trials (RCTs), this literature review provides the most extensive and up-to-date analysis* of the effect of ω-3 fatty-acid enriched PN on patient outcomes.

According to this analysis, adding ω-3 fatty acids to PN significantly reduces the risk of infections by 40 % and the length of ICU and hospital stays by two days compared with standard PN. Moreover, the analysis revealed that PN enriched with fish oil significantly reduces sepsis by 56 %. An analysis of RCTs reporting laboratory parameters furthermore suggests that ω-3 fatty-acid enriched PN can have beneficial effects on liver chemistry, antioxidant status, markers of inflammation, and the fatty-acid profile. The authors conclude that lipid emulsions enriched with ω-3 fatty acids should be preferred over standard lipid emulsions in patients needing PN.

About the review and meta-analysis

The meta-analysis by Lorenzo Pradelli and colleagues was published in the Journal of Parenteral and Enteral Nutrition in June 2019. The review includes a total of 49 RCTs with 3641 adult hospital patients comparing outcomes between groups receiving ω-3 fatty-acid enriched lipid emulsions and groups receiving standard lipid emulsions as part of PN. Only those RCTs were included, in which PN accounted for at least 70 % of the patients' daily energy provision. RCTs with off-label interventions were excluded from the analysis.

For more information you can find the full publication at https://onlinelibrary.wiley.com/doi/full/10.1002/jpen.1672.

* Authors qualify this statement as being "…to the best of our knowledge…"

About Fresenius Kabi

Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company's products and services are used to help care for critically and chronically ill patients. Fresenius Kabi's product portfolio comprises a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the devices for administering these products. In the field of biosimilars, we focus on autoimmune diseases and oncology. In 2019, the first biosimilar product by Fresenius Kabi was launched. Within transfusion medicine and cell technologies, Fresenius Kabi offers products for collection and processing of blood and cell components.

With its corporate philosophy of "caring for life," the company is committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face.

Fresenius Kabi employs more than 37,000 people worldwide. In 2018, the company reported sales of more than €6.5 billion. Fresenius Kabi AG is a wholly owned subsidiary of Fresenius SE & Co. KGaA healthcare group.

For more information, visit the company's website at https://www.fresenius-kabi.com.

References:
1. Pradelli L, Mayer K, Klek S et al. ω-3 Fatty-Acid Enriched Parenteral Nutrition in Hospitalized Patients: Systematic Review With Meta-Analysis and Trial Sequential Analysis. JPEN J Parenter Enteral Nutr. 2019.

For press inquiries, please contact:
Nina Espiritu
Edelman GmbH
Barmbeker Str 4, 22303 Hamburg, Germany
T: +49-(0)69-401254-345
nina.espiritu@edelman.com


TRENDING

OPINION/BLOG/INTERVIEW

JNU Administration's 100-meter challenge before JNUSU

For the first time in its history, Jawaharlal Nehru University JNU Administration is seeking permanent deployment of local police to keep protesting students at 100 meters away from the Administrative Block. It would be interesting to see h...

Sentiment Analysis of Twitter users during COP25: Governments losing trust on Climate Action

Sentiment analysis of Twitter users during COP25 in Madrid, being held from December 2-13, shows widespread fear on climate change due to global warming but almost no trust on governments in meeting the emission targets. In the analysis the...

These innovators are making humanitarian response more efficient

These alarming trends prompt a call for the world to not only address the ongoing crisis but also to adopt innovative approaches to fulfill the growing humanitarian needs in such emergencies. ...

Hyderabad Encounter: A sentiment analysis of public mood on day of encounter

Sentiment analysis of twitter users revealed that they showered salutes on Hyderabad police for eliminating alleged gang rapists of the veterinary doctor but only a few believe in cops version of successive events leading to encounter....

Videos

Latest News

People News Roundup: 'Bridget Jones' actor Colin Firth and wife split after 22 years

Following is a summary of current peoples news briefs. Bridget Jones actor Colin Firth and wife split after 22 yearsBritish actor Colin Firth and his Italian wife on Friday announced they had split up after 22 years of marriage. Firth, 59, ...

UPDATE 1-French CGT union threatens more protests over pensions plan

Four branches of Frances hardline CGT union, including railway and transport workers, threatened on Sunday to step up protests unless the government withdraws its pension reform proposal this week.In a major overhaul of Frances complex pens...

Mahomes, Chiefs romp over Broncos in snow

Quarterback Patrick Mahomes passed for 340 yards and two touchdowns in the snow Sunday as the Kansas City Chiefs won their fourth straight, stuffing the Denver Broncos 23-3 at Kansas City, Mo. Snow began accumulating three hours before kick...

Fox plays video showing Pats filming Bengals sideline

Fox Sports on Sunday morning played footage it claimed to show members of the Patriots staff filming the Cincinnati Bengals sideline last week in an incident that has sparked another NFL investigation into New England. The video, obtained b...

Give Feedback